Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors

Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platform Brings decades of experience in developing strong pipelines of antibody-based drugs from platforms,…

Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors

Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platform Brings decades of experience in developing strong pipelines of antibody-based drugs from platforms,…

Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors

Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platform Brings decades of experience in developing strong pipelines of antibody-based drugs from platforms,…